Loading…

Effect of tetramethylpyrazine on potassium channels to lower calcium concentration in cultured aortic smooth muscle cells

Summary 1. Tetramethylpyrazine (TMP) is one of the active principles contained in Ligusticum chuanxiong Hort. (Umbelliferae), a herb that has been used widely in China to treat vascular disorders. 2. In an attempt to elucidate the possible mechanisms of action of TMP, the effect of TMP on intracellu...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental pharmacology & physiology 2003-10, Vol.30 (10), p.793-798
Main Authors: Wong, Kar-Lok, Chan, Paul, Huang, Wei-Chan, Yang, Tzyy-Lin, Liu, I-Min, Lai, Tung-Yuan, Tsai, Chin-Chuan, Cheng, Juei-Tang
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4693-c2c9e4456c095bb3ee2233868199a148edbb8e976195a43417b825d54c6ea0653
cites cdi_FETCH-LOGICAL-c4693-c2c9e4456c095bb3ee2233868199a148edbb8e976195a43417b825d54c6ea0653
container_end_page 798
container_issue 10
container_start_page 793
container_title Clinical and experimental pharmacology & physiology
container_volume 30
creator Wong, Kar-Lok
Chan, Paul
Huang, Wei-Chan
Yang, Tzyy-Lin
Liu, I-Min
Lai, Tung-Yuan
Tsai, Chin-Chuan
Cheng, Juei-Tang
description Summary 1. Tetramethylpyrazine (TMP) is one of the active principles contained in Ligusticum chuanxiong Hort. (Umbelliferae), a herb that has been used widely in China to treat vascular disorders. 2. In an attempt to elucidate the possible mechanisms of action of TMP, the effect of TMP on intracellular calcium concentrations ([Ca2+]i) was investigated in cultured vascular smooth muscle (A7r5) cells using the Ca2+‐sensitive dye Fura‐2 as an indicator. 3. The increase in [Ca2+]i in A7r5 cells produced by vasopressin (1 µmol/L) or phenylephrine (1 µmol/L) was attenuated by TMP in a concentration‐dependent manner. Only inhibitors specific to ATP‐sensitive potassium (KATP) channels or small conductance calcium‐activated potassium (SKCa) channels attenuated the action of TMP (10 µmol/L) on [Ca2+]i. However, blockers of other K+ channels failed to modify the inhibitory action of TMP (10 µmol/L) on [Ca2+]i. 4. The action of TMP on membrane potential in A7r5 cells was monitored by the fluorescence of bisoxonol. Tetramethylpyrazine caused a concentration‐dependent inhibition of changes in membrane potential elicited by KCl (20 mmol/L) or phenylephrine (1 µmol/L), an effect that was totally reversed by glibenclamide (100 µmol/L) and apamin (100 nmol/L) in combination. 5. The results obtained indicate that the decrease in [Ca2+]i in A7r5 cells produced by TMP is mediated mainly by opening of KATP and/or SKCa channels.
doi_str_mv 10.1046/j.1440-1681.2003.03913.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75724766</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75724766</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4693-c2c9e4456c095bb3ee2233868199a148edbb8e976195a43417b825d54c6ea0653</originalsourceid><addsrcrecordid>eNqNkE2P0zAQhi0EYsvCX0A-cUvwd5IDB1TKdqUVcADt0XLcierixMV2tA2_nmRbLdc9jaV5n5nxgxCmpKREqI-HkgpBCqpqWjJCeEl4Q3l5eoFWT42XaEU4kQWtK3KF3qR0IIRIovhrdEWFpEowskLTpuvAZhw6nCFH00PeT_44RfPXDYDDgI8hm5Tc2GO7N8MAPuEcsA8PELE13j52wmBhmPHsZsIN2I4-jxF22ISYncWpDyHvcT8m6wFb8D69Ra864xO8u9Rr9Ovr5ud6W9x9v7ldf74rrFANLyyzDQghlSWNbFsOwBjn9fzBpjFU1LBr2xqaStFGGsEFrdqayZ0UVoEhSvJr9OE89xjDnxFS1r1LywVmgDAmXcmKiUqpOVifgzaGlCJ0-hhdb-KkKdGLdn3Qi1292NWLdv2oXZ9m9P1lx9j2sPsPXjzPgU_nwIPzMD17sF5vfiyvmS_OvEsZTk-8ib-1qngl9f23G_1lxtl2y_Q9_wc2m6Hq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75724766</pqid></control><display><type>article</type><title>Effect of tetramethylpyrazine on potassium channels to lower calcium concentration in cultured aortic smooth muscle cells</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><source>SPORTDiscus with Full Text</source><creator>Wong, Kar-Lok ; Chan, Paul ; Huang, Wei-Chan ; Yang, Tzyy-Lin ; Liu, I-Min ; Lai, Tung-Yuan ; Tsai, Chin-Chuan ; Cheng, Juei-Tang</creator><creatorcontrib>Wong, Kar-Lok ; Chan, Paul ; Huang, Wei-Chan ; Yang, Tzyy-Lin ; Liu, I-Min ; Lai, Tung-Yuan ; Tsai, Chin-Chuan ; Cheng, Juei-Tang</creatorcontrib><description>Summary 1. Tetramethylpyrazine (TMP) is one of the active principles contained in Ligusticum chuanxiong Hort. (Umbelliferae), a herb that has been used widely in China to treat vascular disorders. 2. In an attempt to elucidate the possible mechanisms of action of TMP, the effect of TMP on intracellular calcium concentrations ([Ca2+]i) was investigated in cultured vascular smooth muscle (A7r5) cells using the Ca2+‐sensitive dye Fura‐2 as an indicator. 3. The increase in [Ca2+]i in A7r5 cells produced by vasopressin (1 µmol/L) or phenylephrine (1 µmol/L) was attenuated by TMP in a concentration‐dependent manner. Only inhibitors specific to ATP‐sensitive potassium (KATP) channels or small conductance calcium‐activated potassium (SKCa) channels attenuated the action of TMP (10 µmol/L) on [Ca2+]i. However, blockers of other K+ channels failed to modify the inhibitory action of TMP (10 µmol/L) on [Ca2+]i. 4. The action of TMP on membrane potential in A7r5 cells was monitored by the fluorescence of bisoxonol. Tetramethylpyrazine caused a concentration‐dependent inhibition of changes in membrane potential elicited by KCl (20 mmol/L) or phenylephrine (1 µmol/L), an effect that was totally reversed by glibenclamide (100 µmol/L) and apamin (100 nmol/L) in combination. 5. The results obtained indicate that the decrease in [Ca2+]i in A7r5 cells produced by TMP is mediated mainly by opening of KATP and/or SKCa channels.</description><identifier>ISSN: 0305-1870</identifier><identifier>EISSN: 1440-1681</identifier><identifier>DOI: 10.1046/j.1440-1681.2003.03913.x</identifier><identifier>PMID: 14516420</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Pty</publisher><subject>Animals ; Aorta - cytology ; Aorta - drug effects ; Aorta - metabolism ; bisoxonol ; Calcium - antagonists &amp; inhibitors ; Calcium - metabolism ; Cell Line ; cultured vascular smooth muscle cells ; Dose-Response Relationship, Drug ; Fura-2 ; intracellular calcium concentrations ; Muscle, Smooth, Vascular - cytology ; Muscle, Smooth, Vascular - drug effects ; Muscle, Smooth, Vascular - metabolism ; potassium channel blockers ; Potassium Channel Blockers - pharmacology ; Potassium Channels - metabolism ; Pyrazines - pharmacology ; Rats ; tetramethylpyrazine</subject><ispartof>Clinical and experimental pharmacology &amp; physiology, 2003-10, Vol.30 (10), p.793-798</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4693-c2c9e4456c095bb3ee2233868199a148edbb8e976195a43417b825d54c6ea0653</citedby><cites>FETCH-LOGICAL-c4693-c2c9e4456c095bb3ee2233868199a148edbb8e976195a43417b825d54c6ea0653</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14516420$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wong, Kar-Lok</creatorcontrib><creatorcontrib>Chan, Paul</creatorcontrib><creatorcontrib>Huang, Wei-Chan</creatorcontrib><creatorcontrib>Yang, Tzyy-Lin</creatorcontrib><creatorcontrib>Liu, I-Min</creatorcontrib><creatorcontrib>Lai, Tung-Yuan</creatorcontrib><creatorcontrib>Tsai, Chin-Chuan</creatorcontrib><creatorcontrib>Cheng, Juei-Tang</creatorcontrib><title>Effect of tetramethylpyrazine on potassium channels to lower calcium concentration in cultured aortic smooth muscle cells</title><title>Clinical and experimental pharmacology &amp; physiology</title><addtitle>Clin Exp Pharmacol Physiol</addtitle><description>Summary 1. Tetramethylpyrazine (TMP) is one of the active principles contained in Ligusticum chuanxiong Hort. (Umbelliferae), a herb that has been used widely in China to treat vascular disorders. 2. In an attempt to elucidate the possible mechanisms of action of TMP, the effect of TMP on intracellular calcium concentrations ([Ca2+]i) was investigated in cultured vascular smooth muscle (A7r5) cells using the Ca2+‐sensitive dye Fura‐2 as an indicator. 3. The increase in [Ca2+]i in A7r5 cells produced by vasopressin (1 µmol/L) or phenylephrine (1 µmol/L) was attenuated by TMP in a concentration‐dependent manner. Only inhibitors specific to ATP‐sensitive potassium (KATP) channels or small conductance calcium‐activated potassium (SKCa) channels attenuated the action of TMP (10 µmol/L) on [Ca2+]i. However, blockers of other K+ channels failed to modify the inhibitory action of TMP (10 µmol/L) on [Ca2+]i. 4. The action of TMP on membrane potential in A7r5 cells was monitored by the fluorescence of bisoxonol. Tetramethylpyrazine caused a concentration‐dependent inhibition of changes in membrane potential elicited by KCl (20 mmol/L) or phenylephrine (1 µmol/L), an effect that was totally reversed by glibenclamide (100 µmol/L) and apamin (100 nmol/L) in combination. 5. The results obtained indicate that the decrease in [Ca2+]i in A7r5 cells produced by TMP is mediated mainly by opening of KATP and/or SKCa channels.</description><subject>Animals</subject><subject>Aorta - cytology</subject><subject>Aorta - drug effects</subject><subject>Aorta - metabolism</subject><subject>bisoxonol</subject><subject>Calcium - antagonists &amp; inhibitors</subject><subject>Calcium - metabolism</subject><subject>Cell Line</subject><subject>cultured vascular smooth muscle cells</subject><subject>Dose-Response Relationship, Drug</subject><subject>Fura-2</subject><subject>intracellular calcium concentrations</subject><subject>Muscle, Smooth, Vascular - cytology</subject><subject>Muscle, Smooth, Vascular - drug effects</subject><subject>Muscle, Smooth, Vascular - metabolism</subject><subject>potassium channel blockers</subject><subject>Potassium Channel Blockers - pharmacology</subject><subject>Potassium Channels - metabolism</subject><subject>Pyrazines - pharmacology</subject><subject>Rats</subject><subject>tetramethylpyrazine</subject><issn>0305-1870</issn><issn>1440-1681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqNkE2P0zAQhi0EYsvCX0A-cUvwd5IDB1TKdqUVcADt0XLcierixMV2tA2_nmRbLdc9jaV5n5nxgxCmpKREqI-HkgpBCqpqWjJCeEl4Q3l5eoFWT42XaEU4kQWtK3KF3qR0IIRIovhrdEWFpEowskLTpuvAZhw6nCFH00PeT_44RfPXDYDDgI8hm5Tc2GO7N8MAPuEcsA8PELE13j52wmBhmPHsZsIN2I4-jxF22ISYncWpDyHvcT8m6wFb8D69Ra864xO8u9Rr9Ovr5ud6W9x9v7ldf74rrFANLyyzDQghlSWNbFsOwBjn9fzBpjFU1LBr2xqaStFGGsEFrdqayZ0UVoEhSvJr9OE89xjDnxFS1r1LywVmgDAmXcmKiUqpOVifgzaGlCJ0-hhdb-KkKdGLdn3Qi1292NWLdv2oXZ9m9P1lx9j2sPsPXjzPgU_nwIPzMD17sF5vfiyvmS_OvEsZTk-8ib-1qngl9f23G_1lxtl2y_Q9_wc2m6Hq</recordid><startdate>200310</startdate><enddate>200310</enddate><creator>Wong, Kar-Lok</creator><creator>Chan, Paul</creator><creator>Huang, Wei-Chan</creator><creator>Yang, Tzyy-Lin</creator><creator>Liu, I-Min</creator><creator>Lai, Tung-Yuan</creator><creator>Tsai, Chin-Chuan</creator><creator>Cheng, Juei-Tang</creator><general>Blackwell Science Pty</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200310</creationdate><title>Effect of tetramethylpyrazine on potassium channels to lower calcium concentration in cultured aortic smooth muscle cells</title><author>Wong, Kar-Lok ; Chan, Paul ; Huang, Wei-Chan ; Yang, Tzyy-Lin ; Liu, I-Min ; Lai, Tung-Yuan ; Tsai, Chin-Chuan ; Cheng, Juei-Tang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4693-c2c9e4456c095bb3ee2233868199a148edbb8e976195a43417b825d54c6ea0653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Aorta - cytology</topic><topic>Aorta - drug effects</topic><topic>Aorta - metabolism</topic><topic>bisoxonol</topic><topic>Calcium - antagonists &amp; inhibitors</topic><topic>Calcium - metabolism</topic><topic>Cell Line</topic><topic>cultured vascular smooth muscle cells</topic><topic>Dose-Response Relationship, Drug</topic><topic>Fura-2</topic><topic>intracellular calcium concentrations</topic><topic>Muscle, Smooth, Vascular - cytology</topic><topic>Muscle, Smooth, Vascular - drug effects</topic><topic>Muscle, Smooth, Vascular - metabolism</topic><topic>potassium channel blockers</topic><topic>Potassium Channel Blockers - pharmacology</topic><topic>Potassium Channels - metabolism</topic><topic>Pyrazines - pharmacology</topic><topic>Rats</topic><topic>tetramethylpyrazine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wong, Kar-Lok</creatorcontrib><creatorcontrib>Chan, Paul</creatorcontrib><creatorcontrib>Huang, Wei-Chan</creatorcontrib><creatorcontrib>Yang, Tzyy-Lin</creatorcontrib><creatorcontrib>Liu, I-Min</creatorcontrib><creatorcontrib>Lai, Tung-Yuan</creatorcontrib><creatorcontrib>Tsai, Chin-Chuan</creatorcontrib><creatorcontrib>Cheng, Juei-Tang</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and experimental pharmacology &amp; physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wong, Kar-Lok</au><au>Chan, Paul</au><au>Huang, Wei-Chan</au><au>Yang, Tzyy-Lin</au><au>Liu, I-Min</au><au>Lai, Tung-Yuan</au><au>Tsai, Chin-Chuan</au><au>Cheng, Juei-Tang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of tetramethylpyrazine on potassium channels to lower calcium concentration in cultured aortic smooth muscle cells</atitle><jtitle>Clinical and experimental pharmacology &amp; physiology</jtitle><addtitle>Clin Exp Pharmacol Physiol</addtitle><date>2003-10</date><risdate>2003</risdate><volume>30</volume><issue>10</issue><spage>793</spage><epage>798</epage><pages>793-798</pages><issn>0305-1870</issn><eissn>1440-1681</eissn><abstract>Summary 1. Tetramethylpyrazine (TMP) is one of the active principles contained in Ligusticum chuanxiong Hort. (Umbelliferae), a herb that has been used widely in China to treat vascular disorders. 2. In an attempt to elucidate the possible mechanisms of action of TMP, the effect of TMP on intracellular calcium concentrations ([Ca2+]i) was investigated in cultured vascular smooth muscle (A7r5) cells using the Ca2+‐sensitive dye Fura‐2 as an indicator. 3. The increase in [Ca2+]i in A7r5 cells produced by vasopressin (1 µmol/L) or phenylephrine (1 µmol/L) was attenuated by TMP in a concentration‐dependent manner. Only inhibitors specific to ATP‐sensitive potassium (KATP) channels or small conductance calcium‐activated potassium (SKCa) channels attenuated the action of TMP (10 µmol/L) on [Ca2+]i. However, blockers of other K+ channels failed to modify the inhibitory action of TMP (10 µmol/L) on [Ca2+]i. 4. The action of TMP on membrane potential in A7r5 cells was monitored by the fluorescence of bisoxonol. Tetramethylpyrazine caused a concentration‐dependent inhibition of changes in membrane potential elicited by KCl (20 mmol/L) or phenylephrine (1 µmol/L), an effect that was totally reversed by glibenclamide (100 µmol/L) and apamin (100 nmol/L) in combination. 5. The results obtained indicate that the decrease in [Ca2+]i in A7r5 cells produced by TMP is mediated mainly by opening of KATP and/or SKCa channels.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Pty</pub><pmid>14516420</pmid><doi>10.1046/j.1440-1681.2003.03913.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0305-1870
ispartof Clinical and experimental pharmacology & physiology, 2003-10, Vol.30 (10), p.793-798
issn 0305-1870
1440-1681
language eng
recordid cdi_proquest_miscellaneous_75724766
source Wiley-Blackwell Read & Publish Collection; SPORTDiscus with Full Text
subjects Animals
Aorta - cytology
Aorta - drug effects
Aorta - metabolism
bisoxonol
Calcium - antagonists & inhibitors
Calcium - metabolism
Cell Line
cultured vascular smooth muscle cells
Dose-Response Relationship, Drug
Fura-2
intracellular calcium concentrations
Muscle, Smooth, Vascular - cytology
Muscle, Smooth, Vascular - drug effects
Muscle, Smooth, Vascular - metabolism
potassium channel blockers
Potassium Channel Blockers - pharmacology
Potassium Channels - metabolism
Pyrazines - pharmacology
Rats
tetramethylpyrazine
title Effect of tetramethylpyrazine on potassium channels to lower calcium concentration in cultured aortic smooth muscle cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T17%3A49%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20tetramethylpyrazine%20on%20potassium%20channels%20to%20lower%20calcium%20concentration%20in%20cultured%20aortic%20smooth%20muscle%20cells&rft.jtitle=Clinical%20and%20experimental%20pharmacology%20&%20physiology&rft.au=Wong,%20Kar-Lok&rft.date=2003-10&rft.volume=30&rft.issue=10&rft.spage=793&rft.epage=798&rft.pages=793-798&rft.issn=0305-1870&rft.eissn=1440-1681&rft_id=info:doi/10.1046/j.1440-1681.2003.03913.x&rft_dat=%3Cproquest_cross%3E75724766%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4693-c2c9e4456c095bb3ee2233868199a148edbb8e976195a43417b825d54c6ea0653%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=75724766&rft_id=info:pmid/14516420&rfr_iscdi=true